Stimulus properties of a new designer drug: 4-methylaminorex (“U4Euh”)

https://doi.org/10.1016/0091-3057(90)90282-MGet rights and content

Abstract

Like other phenylisopropylamine derivatives, 4-methylaminorex is a central stimulant. The cis isomer of 4-methylaminorex (“U4Euh”; “ICE”) has appeared on the clandestine market as a novel designer drug and was recently classified as a Schedule I substance. In the present investigation, the stimulus properties of racemic cis, racemic trans, and all four individual optical isomers of 4-methylaminorex were examined in rats trained to discriminate 1 mg/kg of S(+)amphetamine sulfate from saline. The S(+)amphetamine stimulus generalized to all of the agents investigated and the relative potencies of the optical isomers (followed by ED50 values) were as follows:trans(4S,5S) (0.25 mg/kg) >cis(4S,5R) (1.2 mg/kg) = cis(4R,5S) (1.5 mg/kg) >trans(4R, 5R). The trans(4R,5R) isomer did not completely substitute for S(+)amphetamine unless a longer (i.e., 60-min) presession injection interval was used, suggesting that it has a longer duration of onset that the other isomers of 4-methylaminorex. The results, which are consistent with established structure-activity relationships, suggest that the trans(4S,5S) isomer (which has not been scheduled) is similar in potency to (+)amphetamine (ED50=0.4 mg/kg) and is more potent than either of the cis isomers.

References (15)

  • R.A. Glennon et al.

    Stimulus properties of 1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDA) analogs

    Pharmacol. Biochem. Behav.

    (1988)
  • R.A. Glennon et al.

    Methcathinone: A new and potent amphetamine-like agent

    Pharmacol. Biochem. Behav.

    (1987)
  • F.T. Davis et al.

    A fatality involving U4Euh, a cyclic derivative of phenylpropanolamine

    J. Forensic Sci.

    (1988)
  • M.D. Fairchild et al.

    The central locomotor stimulatory activity and acute toxicity of the ephedrine and norephedrine isomers in mice

    J. Pharmacol. Exp. Ther.

    (1967)
  • Federal Register

    Schedules of controlled substances;

    Placement of (±)cis-4-methylaminorex into Schedule I: April 13, 1989

    (1989)
  • D. Finney

    Probit analysis

    (1952)
  • R.A. Glennon

    Psychoactive phenylisopropylamines

There are more references available in the full text version of this article.

Cited by (24)

  • Pharmacological characterization of the aminorex analogs 4-MAR, 4,4′-DMAR, and 3,4-DMAR

    2019, NeuroToxicology
    Citation Excerpt :

    In contrast, substance users report effects of 4-MAR to be more like methamphetamine than MDMA (Erowid, 2002), consistent with the present in vitro pharmacological data. In vivo studies with 4-MAR in rats and primates also revealed amphetamine-like psychostimulant properties (Batsche et al., 1994; Glennon and Misenheimer, 1990; Mansbach et al., 1990). Furthermore, 4-MAR and its isomers produced conditioned place preference, which was mediated via dopamine D1 and D2 receptors (Meririnne et al., 2005) in line with its dopaminergic action.

  • Recreational use of aminorex and pulmonary hypertension

    2000, Chest
    Citation Excerpt :

    Officials for the Drug Enforcement Administrationconfirmed that the cis-isomer of 4-methyl-aminorex (street names,“U-4-E-uh” [pronounced euphoria] or “ice”) has appeared onthe clandestine market as a “designer” drug alternative tomethamphetamine (street name, “crank”). 4-Methyl-aminorex (Fig 1), which has gained attention due to its potential as a centralstimulant of abuse and because of the ease with which it issynthesized, was recently classified as a schedule Isubstance.3 The drug is generally synthesized from theover-the-counter diet pill phenylpropanolamine HCl and is smoked as thefree base or the HCl salt.

  • Stimulus properties of some analogues of 4-methylaminorex

    1995, Pharmacology, Biochemistry and Behavior
  • Evaluation of the abuse liability of aminorex

    1994, Drug and Alcohol Dependence
View all citing articles on Scopus
View full text